PortfoliosLab logoPortfoliosLab logo
ISIN
CA03842P1009

Highlights

Market Cap
$115.92K
Enterprise Value
$7.15M
EPS (TTM)
-$0.01
Total Revenue (TTM)
$84.32K
Gross Profit (TTM)
$45.38K
EBITDA (TTM)
$126.17K
Year Range
$0.00 - $0.00
ROA (TTM)
-8.25%
ROE (TTM)
4.62%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

AQQRF Performance Chart

Aquarius Surgical Technologies Inc (AQQRF) is up 0.0% since the beginning of the year. At $0 per share, AQQRF is currently trading at its 52-week high. Investors who bought $1,000 worth of AQQRF shares 5 years ago would now be looking at an investment worth $29.


Loading charts...

S&P 500 Index

Returns By Period

Aquarius Surgical Technologies Inc (AQQRF) has returned 0.00% so far this year and 0.00% over the past 12 months.


Aquarius Surgical Technologies Inc

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
0.00%
5Y*
-50.69%
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AQQRF Monthly Returns History

Based on dividend-adjusted daily data since Nov 8, 2019, AQQRF's average daily return is +0.32%, while the average monthly return is +5.20%. At this rate, an investment would double in approximately 1.1 years.

Historically, 8% of months were positive and 93% were negative. The best month was Nov 2021 with a return of +293.3%, while the worst month was Sep 2021 at -99.0%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, AQQRF closed higher 1% of trading days. The best single day was Nov 17, 2021 with a return of +293.3%, while the worst single day was Sep 3, 2021 at -99.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.00%0.00%0.00%0.00%0.00%0.00%0.00%
20250.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
20240.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
20230.00%0.00%0.00%-79.00%0.00%0.00%0.00%0.00%0.00%-79.00%
20220.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%238.98%0.00%0.00%0.00%238.98%
2021179.17%26.93%-37.60%-32.38%29.45%0.00%0.00%0.00%-98.96%0.00%293.33%0.00%-92.07%

Benchmark Metrics

Aquarius Surgical Technologies Inc has an annualized alpha of 130.82%, beta of -0.13, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 14, 2019.

  • This stock participated in 108.35% of S&P 500 Index downside but only -100.88% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of -0.13 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
130.82%
Beta
-0.13
0.00
Upside Capture
-100.88%
Downside Capture
108.35%

Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Aquarius Surgical Technologies Inc (AQQRF) and compare them to S&P 500 Index.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Dividends

Dividend History


Aquarius Surgical Technologies Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aquarius Surgical Technologies Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aquarius Surgical Technologies Inc was 99.56%, occurring on Sep 3, 2021. The portfolio has not yet recovered.

The current Aquarius Surgical Technologies Inc drawdown is 98.78%.


Related event

Drawdown

Fall

Recovery

Underwater

2021 bear market2021
-99.56%Sep 2021
1y 9mo
6y 6moNov 2019 - now

Drawdown Indicators


AQQRFBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.56%

-56.78%

-42.78%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

-9.10%

+9.10%

Max Drawdown (3Y)

Largest decline over 3 years

0.00%

-18.90%

+18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-98.96%

-25.43%

-73.53%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-98.78%

0.00%

-98.78%

Average Drawdown

Average peak-to-trough decline

-87.87%

-10.72%

-77.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

1.97%

-1.97%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aquarius Surgical Technologies Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Aquarius Surgical Technologies Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AQQRF relative to other companies in the Medical Devices industry. Currently, AQQRF has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with AQQRF

Add Aquarius Surgical Technologies Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with AQQRF